TRH and acute myeloid leukemia: Given that AML patients had a higher expression of TRH compared to healthy populations (Figure 1), and the Kaplan–Meier analysis of the TRH-low group indicated an inferior outcome for AML patients [9], we further explored the prognostic value of TRH expression in different AML FAB subgroups.